Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling |
Ham, Won-Kook
(Department of Dermatology, College of Medicine, The Catholic University of Korea)
Lee, Eun-Jung (Department of Dermatology, College of Medicine, The Catholic University of Korea) Jeon, Myung Shin (Translational Research Center, Department of Molecular Biomedicine, IRIMS, and College of Medicine, Inha University) Kim, Hae-Young (Department of Dermatology, College of Medicine, The Catholic University of Korea) Agrahari, Gaurav (Department of Dermatology, College of Medicine, The Catholic University of Korea) An, Eun-Joo (Department of Dermatology, College of Medicine, The Catholic University of Korea) Bang, Chul Hwan (Department of Dermatology, College of Medicine, The Catholic University of Korea) Kim, Doo-Sik (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) Kim, Tae-Yoon (Department of Dermatology, College of Medicine, The Catholic University of Korea) |
1 | Sumiyoshi K, Nakao A, Ushio H et al (2002) Transforming growth factor-beta1 suppresses atopic dermatitis-like skin lesions in NC/Nga mice. Clin Exp Allergy 32, 309-314 DOI |
2 | Suping Zhang TF, Lixia Zhang, Ran Zhang et al (2007) Smad7 antagonizes TGF-β signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 27, 4488-4499 DOI |
3 | Sugai M, Gonda H, Kusunoki T, Katakai T, Yokota Y, Shimizu A (2003) Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol 4, 25-30 DOI |
4 | Di J, Pang J, Pu X et al (2009) Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet 192, 60-67 DOI |
5 | Heikenwalder M, Polymenidou M, Junt T et al (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10, 187-192 DOI |
6 | Liu N, Ohnishi N, Ni L, Akira S, Bacon KB (2003) CpG directly induced T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 4, 687-693 DOI |
7 | Okamoto A, Kawamura T, Kanbe K et al (2005) Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-beta. Int Immunol 17, 705-712 DOI |
8 | Quong MW, Harris DP, Swain SL, Murre C (1999) E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J 18, 6307-6318 DOI |
9 | Sugai M, Gonda H, Kusunoki T, Katakai T, Yokota Y, Shimizu A (2003) Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol 4, 25-30 DOI |
10 | Sugai M, Gonda H, Nambu Y, Yokota Y, Shimizu A (2004) Role of Id proteins in B lymphocyte activation: new insights from knockout mouse studies. J Mol Med 82, 592-599 DOI |
11 | Kim Y, Lee K, Kwon H, Kim D, Kim T (2007) Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN. Int Arch Aller Immunol 144, 315-324 DOI |
12 | Nabe T, Zindl CL, Jung YW et al (2005) Induction of a late asthmatic response associated with airway inflammation in mice. Eur J Pharmacol 521, 144-155 DOI |
13 | Jin-ming Di JP, Xiao-yong Pu, Yan Zhang et al (2009) Toll-like receptor 9 agonists promote IL-8 and TGF-b1 production via activation of nuclear factor kB in PC-3 cells. Cancer Genet Cytogenet 192, 60-67 DOI |
14 | Eibensteiner P, Spitzauer S, Steinberger P, Kraft D, Valenta R (2000) Immunoglobulin E antibodies of atopic individuals exhibit a broad usage of VH-gene families. Immunology 101, 112-119 DOI |
15 | Calman Prussin DDM (2003) IgE, mast cells, basophils, and eosinophils. J Aller Clin Immunol 111, S486-494 |
16 | Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol 8, 205-217 DOI |
17 | Li MO W, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-h regulation of immune responses. Annu Rev Immunol 24, 99-146 DOI |
18 | Anthoni M, Wang G, Deng C, Wolff HJ, Lauerma AI, Alenius HT (2007) Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis. J Invest Dermatol 127, 1923-1929 DOI |
19 | Bhagat L, Zhu FG, Yu D et al (2003) CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents. Biochem Biophys Res Commun 300, 853-861 DOI |
20 | Alexander H, Dalpke SZ, Albrecht I, Heeg K (2002) Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 106, 102-112 DOI |
21 | Verthelyi D, Kenney RT, Seder RA, Gam A, Friedag B, Klinman DM (2002) CpG oligodeoxynucleotides as vaccine adjuvants in primates. J Immunol 168, 1659-1663 DOI |
22 | Jiang W, Lederman M, Harding CV, Rodriguez B, Mohner RJ, Sieg SF (2007) TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 37, 2205-2213 DOI |
23 | Heikenwalder M, Polymenidou M, Junt T et al (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10, 187-192 DOI |
24 | Serebrisky D, Teper AA, Huang CK et al (2000) CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma. J Immunol 165, 5906-5912 DOI |
25 | Kusunoki T, Sugai M, Gonda H et al (2005) CpG inhibits IgE class switch recombination through suppression of NF kappa B activity, but not through Id2 or Bcl6. Biochem Biophys Res Commun 328, 499-506 DOI |
26 | Tsujimura H, Tamura T, Kong HJ et al (2004) Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 172, 6820-6827 DOI |
27 | Choi YJ, Lee KW, Kwon HJ, Kim DS (2006) Identification of immunostimulatory oligodeoxynucleotide from Escherichia coli genomic DNA. J Biochem Mol Biol 39, 788-793 |
28 | Park S, Kim K, Na K, Kim Y, Kim T (2007) Effect of dendritic cells treated with CpG ODN on atopic dermatitis of Nc/Nga mice. J Biochem Mol Biol 40, 486-493 |
29 | Kootiratrakarn T, Fujimura T, Sano K et al (2005) Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. Eur J Immunol 35, 3277-3286 DOI |
30 | Geha RS, Jabara HH, Brodeur SR (2003) The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 3, 721-732 DOI |
31 | Yanagihara Y (1999) Molecular regulation of human IgE synthesis. Allergol Int 48, 111-119 DOI |
![]() |